Related Experiment Video
Updated: Aug 6, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori diagnosis and management
Ratha-Korn Vilaichone1, Varocha Mahachai, David Y Graham
1Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani, 12120 Thailand.
Gastroenterology Clinics of North America
|August 2, 2006
Summary
H pylori infection treatment faces challenges with current triple therapy failure rates. Extended 14-day regimens and quadruple therapy show improved eradication, necessitating updated treatment guidelines.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Helicobacter pylori (H pylori) is a major global pathogen causing gastritis and related diseases like ulcers and gastric cancer.
- Current first-line triple therapies for H pylori infection have high failure rates (20-40%) due to antibiotic resistance, poor compliance, and short treatment durations.
- Established diagnostic tests exist, but optimal H pylori eradication regimens require further definition.
Purpose of the Study:
- To review and evaluate current and emerging treatment strategies for H pylori infection.
- To identify factors contributing to treatment failure and assess the efficacy of alternative therapeutic regimens.
- To provide recommendations for improved H pylori eradication protocols.
Main Methods:
- Review of recent studies and older observations on H pylori treatment efficacy.
- Comparison of different therapeutic regimens including triple therapy, extended triple therapy, sequential therapy, and quadruple therapy.
- Analysis of factors influencing treatment success, such as duration, drug combinations, and antibiotic resistance.
Main Results:
- Standard 7-10 day triple therapies exhibit significant failure rates.
- Extending triple therapy to 14 days or adding a third antibiotic improves cure rates.
- Sequential and classic quadruple therapies (including bismuth, PPI, metronidazole, tetracycline) demonstrate higher average eradication rates.
- Noninvasive tests like urea breath test or stool antigen assay are standard for confirming eradication.
Conclusions:
- Shorter H pylori treatment durations (7-10 days) are no longer recommended.
- Fourteen-day triple therapy or sequential therapy should be considered over legacy triple therapies.
- Classic quadruple therapy offers the highest eradication rates and should be a primary treatment option in many regions.
- Newer, improved therapies are essential due to decreasing cure rates with existing regimens.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...